FDA Recall Terminated

Natrelle 133 Series Tissue Expanders Product Usage: Natrelle 133 Series Tissue Expander is intended for temporary subcutaneous implantation and require periodic, incremental inflation with sterile saline for injection until the desired amount of tissue is developed.

Recall: Z-2103-2015 · Initiated June 18, 2015

Recall

Recall Number
Z-2103-2015
Event Number
71498
Firm
Allergan Inc
FEI Number
2011068
Product Code
LCJ
Status
Terminated
Root Cause
Incorrect or no expiration date
Initiated
June 18, 2015
Posted
July 18, 2015
Terminated
December 16, 2015
Address
2525 Dupont Dr, Irvine, CA, 92612-1531

Description

Natrelle 133 Series Tissue Expanders Product Usage: Natrelle 133 Series Tissue Expander is intended for temporary subcutaneous implantation and require periodic, incremental inflation with sterile saline for injection until the desired amount of tissue is developed.

Reason

Allergan is recalling the NATRELLE 133 and CUI Series Tissue Expanders because the product shipped was beyond the 47 month shelf life.

Action

A recall letter will be sent on 6/18/15 to all customers who received the NATRELLE 133 and CUI series tissue expanders. The letter provides the problem identified and the action to be taken. Customers are instructed to contact GENCO Pharmaceutical Services if the recall actions on the recall letter are unclear. For product returns, customers are instructed to contact GENCO at (877) 319-8966, 7am to 5pm CST. Customers with credit/reimbursements are instructed to contact Allergan at (800) 811-4148, 7am to 5pm PST. Customers with medical inquiries are instructed to contact (800) 433-8871, option 2, 8am-5pm, PST. Customers with adverse events/product complaints are instructed to call (800) 624-4261, option 3, 8am-5pm CST.

Distribution

US in the state of Canada

Quantity

167 units total (114 units in US)